• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    Momenta Pharmaceuticals Inc. (MNTA)

    -NasdaqGS
    21.27 Down 1.16(5.17%) Jul 2, 4:00PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 8,562   21,179   9,336   10,950  
    Cost of Revenue -   -   -   -  
    Gross Profit 8,562   21,179   9,336   10,950  
    Operating Expenses
    Research Development22,749  26,193  27,508  26,089  
    Selling General and Administrative7,890  11,125  11,103  11,219  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (22,077) (16,139) (29,275) (26,358)
    Income from Continuing Operations
    Total Other Income/Expenses Net200  158  174  202  
    Earnings Before Interest And Taxes(21,877)(15,981)(29,101)(26,156)
    Interest Expense -   -   -   -  
    Income Before Tax(21,877)(15,981)(29,101)(26,156)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(21,877)(15,981)(29,101)(26,156)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (21,877) (15,981) (29,101) (26,156)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (21,877) (15,981) (29,101) (26,156)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.